🇺🇸 FDA
Pipeline program

Atorvastatin 20 Mg Oral Tablet

XJTU1AF2018LSK-91

Unknown small_molecule active

Quick answer

Atorvastatin 20 Mg Oral Tablet for Atherosclerotic Cardiovascular Disease is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Atherosclerotic Cardiovascular Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials